APU
PCYC

Alpine Partners USVI’s PHARMACYCLICS INC PCYC Stock Holding History

Alpine Partners USVI’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,140
Closed -$964K – 179
2013
Q2 		$964K Buy
+12,140
New +$992K 0.31% 49

Other funds holding PCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpine Partners USVI's PCYC Position: Q3 2013 in Review

Alpine Partners USVI sold out of PHARMACYCLICS INC (PCYC) in Q3 2013, closing a stake of 12,140 shares — an estimated $964K sold.

Alpine Partners USVI first reported a position in PCYC in Q2 2013 and held it in 1 quarter. The position peaked at $964K in Q2 2013. 224 funds tracked by Wall St. Rank hold PCYC as of Q3 2013.

  • Alpine Partners USVI reported no remaining PHARMACYCLICS INC position as of Q3 2013 after selling out during the quarter.
  • Alpine Partners USVI sold 12,140 PHARMACYCLICS INC shares in Q3 2013, an estimated $964K.
  • Alpine Partners USVI first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 1 quarter.
  • Alpine Partners USVI's PHARMACYCLICS INC position peaked at $964K in Q2 2013.
  • 224 funds tracked by Wall St. Rank held PHARMACYCLICS INC as of Q3 2013.

Based on Alpine Partners USVI's 13F filing for Q3 2013, filed 14 Nov 2013.